North America’s medical devices industry saw a drop of 7.29% in deal activity during August 2021, when compared with the last 12-month average, led by 22C Capital, Insight Partners and Nordic Capital’s $7.3bn private equity deal with Inovalon Holdings, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 89 medical devices industry deals worth $12.9bn were announced for the region in August 2021, against the 12-month average of 96 deals.
Of all the deal types, venture financing saw most activity in August 2021 with 60 transactions, representing a 67.4% share for the region.
In second place was M&A with 20 deals, followed by private equity deals with nine transactions, respectively capturing a 22.5% and 10.1% share of the overall deal activity for the month.
In terms of value of deals, private equity was the leading category in North America’s medical devices industry with $7.59bn, while M&A and venture financing deals totalled $4.11bn and $1.24bn, respectively.
North America medical devices industry deals in August 2021: Top deals
The top five medical devices deals accounted for 88.6% of the overall value during August 2021.
The combined value of the top five medical devices deals stood at $11.46bn, against the overall value of $12.9bn recorded for the month.
The top five medical devices industry deals of August 2021 tracked by GlobalData were:
1) 22C Capital,Insight Partners and Nordic Capital $7.3bn private equity deal with Inovalon Holdings
2) The $2.5bn acquisition of Smiths Medical by Trulli Bidco
3) Medtronic $1.1bn acquisition deal with Intersect ENT
4) The $340m acquisition of BioVision by Abcam
5) Adams Street Partners,Battery Ventures,Coatue Management,ICONIQ Growth and Sierra Ventures $220m venture financing deal with Reify Health